1,591
Views
5
CrossRef citations to date
0
Altmetric
Research Papers

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants

, , , , , & show all
Pages 1352-1358 | Received 30 Jan 2016, Accepted 30 Dec 2016, Published online: 16 Mar 2017

References

  • Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200:S9-15; https://doi.org/10.1086/605025
  • Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9(5):565-72; PMID:12737740; https://doi.org/10.3201/eid0905.020562
  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. WHO-coordinated Global Rotavirus Surveillance Network. 2008 e stimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41; https://doi.org/10.1016/S1473-3099(11)70253-5
  • Ito H, Otabe O, Katsumi Y, Matsui F, Kidowaki S, Mibayashi A, Nakagomi T, Nakagomi O. The incidence and direct medical cost of hospitalization due to rotavirus gastroenteritis in Kyoto, Japan, as estimated from a retrospective hospital study. Vaccine 2011; 29:7807-10; PMID:21821087; https://doi.org/10.1016/j.vaccine.2011.07.105
  • Kawai K, O'Brien MA, Goveia MG, Mast TC, El Khoury AC. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine 2012; 30:1244-54; PMID:22212128; https://doi.org/10.1016/j.vaccine.2011.12.092
  • Nakagomi T, Kato K, Tsutsumi H, Nakagomi O. The burden of rotavirus gastroenteritis among Japanese children during its peak months: an internet survey. Jpn J Infect Dis 2013; 66:269-75; PMID:23883835; https://doi.org/10.7883/yoken.66.269
  • Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009; 9:11; PMID:19200366; https://doi.org/10.1186/1471-2431-9-11
  • Iwata S, Nakata S, Ukae S, Koizumi Y, Morita Y, Kuroki H, Tanaka Y, Shizuya T, Schödel F, Brown ML, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother 2013; 9:1626-33; PMID:23732903; https://doi.org/10.4161/hv.24846
  • Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan. Jpn J Infect Dis 2011; 64:277-83. PMID:21788701
  • Itzler R, O'Brien MA, Yamabe K, Abe M, Dhankhar P. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan. J Med Econ. 2013; 16:1216-27; PMID:23919721; https://doi.org/10.3111/13696998.2013.831869
  • Hashizume M, Nakagomi T, Nakagomi O. An early detection of decline in rotavirus cases during the 2013/2014 season in Japan as revealed by time-series analysis of national surveillance data. Trop Med Health. 2015; 43:177-81; PMID:26543393; https://doi.org/10.2149/tmh.2015-23
  • World Health Organization. Rotavirus Vaccines WHO Position Paper – January 2013. Wkly Epidemiol Rec 2013; 88:49-64. PMID:23424730
  • Simizu B, Abe S, Yamamoto H, Tano Y, Ota Y, Miyazawa M, Horie H, Satoh K, Wakabayashi K. Development of inactivated poliovirus vaccine derived from Sabin strains. Biologicals 2006; 34:151-4; PMID:16679028; https://doi.org/10.1016/j.biologicals.2006.02.010
  • Shimizu H. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Vaccine 2016; 34:1975-85; PMID:25448090; https://doi.org/10.1016/j.vaccine.2014.11.015
  • Ogawa H. Efficacy and safety of absorbed acellular pertussis-diphtheria-tetanus-sabin strains derived inactivated poliovirus combined vaccine. BIO Clinica 2013; 28:72-79 [in Japanese]
  • Okada K, Miyazaki C, Kino Y, Ozaki T, Hirose M, Ueda K. Phase II and III clinical studies of diphtheria-tetanus-acellular pertussis vaccine containing inactivated polio vaccine derived from sabin strains (DTaP-sIPV). J Infect Dis. 2013; 208:275-83; PMID:23568174; https://doi.org/10.1093/infdis/jit155
  • Rodriguez ZM, Goveia MG, Stek JE, Dallas MJ, Boslego JW, DiNubile MJ, Heaton PM. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States. Pediatr Infect Dis J 2007; 26:221-7; PMID:17484218; https://doi.org/10.1097/01.inf.0000254391.71103.e8
  • Ciarlet M, He S, Lai S, Petrecz M, Yuan G, Liu GF, Mikviman E, Heaton PM, Panzer F, Rose T, et al. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 2009; 28:177-81; PMID:19209092; https://doi.org/10.1097/INF.0b013e31818c0161
  • Vitek CR, Wharton M. Diphtheria Toxoid. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Saunders Elsevier 2008; 139-56
  • Wassilak SGF, Roper MH, Kretsinger K, Orenstein WA. Tetanus toxoid. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Saunders Elsevier 2008; 805-39
  • Kato T. DTaP. J Pediatr Practice 1990; 53:2275-81 [in Japanese]
  • Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Saunders Elsevier 2008; 605-29
  • Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985; 4:213-26; PMID:4023479; https://doi.org/10.1002/sim.4780040211